News
-
-
COMMUNIQUÉ DE PRESSE
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
Xenetic Biosciences collaborates with PeriNess for an exploratory clinical study of DNase I with anti-CD19 CAR T cells in large B cell lymphoma patients at Tel Aviv Sourasky Medical Center -
COMMUNIQUÉ DE PRESSE
FRP Holdings, Inc. Announces Release Date for Its 2025 Second Quarter Earnings and Details for the Earnings Conference Call
FRP Holdings, Inc. (NASDAQ: FRPH) to release Q2 earnings on August 6, 2025, with a conference call on August 7, 2025. Details for access provided. Company involved in real estate business -
COMMUNIQUÉ DE PRESSE
Safe & Green Holdings Restructures Recent Transaction, Reducing Dilution and Complies with NASDAQ Panel Requirements
Safe & Green Holdings Corp. restructures private placement with D. Boral Capital, cancelling Series A and Series B Warrants to reduce dilution by 70%. Complies with NASDAQ standards -
-
-
COMMUNIQUÉ DE PRESSE
Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic -
-
COMMUNIQUÉ DE PRESSE
Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025
Forward Water Technologies Corp. (FWTC) releases financial results for the fifteen-month period ended March 31, 2025. CEO discusses successful trial with iFO™ process and plans for technology expansion -
